SYNLAB Holding Deutschland GmbH
P5, 7 (Street)
Prof. Winfried März is chair of the Clinical Institute of Medical and Chemical Laboratory Diagnostics at the Medical University of Graz, Austria and has become affiliated with the Mannheim Institute of Public Health, Social and Preventive Medicine at the Medical Faculty Mannheim, University of Heidelberg, (www.umm.uni-heidelberg.de/inst/miph/). Dr. März was deputy head the Division of Clinical Chemistry, University of Freiburg until 2003. Dr. März is also a member of the management advisory board of the Synlab Holding GmbH, head of the Synlab Academy for Continued Medical Education and head of business development at the Synlab Services GmbH.
His research interests are epidemiology, the genetics of vascular diseases and the pharmacological treatment of lipid disorders. He has published more than 350 original articles, several book articles and reviews in these fields; He is among the ten mostly cited scientists both in the areas of laboratory medicine and metabolism research in Germany. Dr. März is principal investigator of the Ludwigshafen Risk Factor and Cardiovascular Health Study (LURIC), has been a member of the steering committee of the 4D trial (Die Deutsche Diabetes Dialyse Studie), an endpoint study of atorvastatin in diabetic patients with end-stage renal disease. He has been involved 6th Framework Program (integrated project Bloodomics, grant LSHM-CT-2004-503485) and 7th of Framework Program (integrated project AtheroRemo, Grant Agreement number 201668) of the European Union.« Back to Editorial Board